yttrium radioisotopes has been researched along with Liver Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Argemi, J; Benito, A; Berasain, C; Bilbao, JI; Collantes, M; Idoate, MA; Iñarrairaegui, M; Páramo, M; Peñuelas, I; Quincoces, G; Quiroga, J; Rodríguez-Fraile, M; Sangro, B; Santamaría, E | 1 |
| Bercu, ZL; Brandon, DC; Elsayed, M; Ermentrout, RM; Galt, JR; Kokabi, N; Schuster, DM; Sethi, I; Whitmore, M | 1 |
| Kapila, N; McElroy, L; Samoylova, ML; Segovia, MC; Suhocki, P | 1 |
| Dhingra, S; Fiel, MI; Kim, E; Mabel Ko, H; Schwartz, M; Thung, SN; Ward, SC | 1 |
| Braat, MN; Lam, MG; van den Bosch, MA; van Erpecum, KJ; Zonnenberg, BA | 1 |
| Anne, PR; Bar Ad, V; Brown, DB; Doyle, LA; Eschelman, DJ; Gonsalves, CF; McCann, JW; Parker, L; Piana, PM; Sato, T | 1 |
| Goris, ML; Iagaru, AH; Lam, MG; Louie, JD; Sze, DY | 1 |
| Allison, C | 1 |
| Atassi, B; Gates, VL; Kulik, L; Larson, AC; Lewandowski, RJ; Mulcahy, MF; Omary, RA; Rhee, TK; Ryu, RK; Salem, R; Sato, KT; Young, JY | 1 |
1 review(s) available for yttrium radioisotopes and Liver Diseases
| Article | Year |
|---|---|
Radioembolization-induced liver disease: a systematic review.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Diseases; Liver Neoplasms; Microspheres; Radiation Injuries; Radiopharmaceuticals; Radiotherapy; Yttrium Radioisotopes | 2017 |
1 trial(s) available for yttrium radioisotopes and Liver Diseases
| Article | Year |
|---|---|
Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Body Burden; Carcinoma, Hepatocellular; Dose-Response Relationship, Radiation; Embolization, Therapeutic; Female; Humans; Liver Diseases; Liver Neoplasms; Male; Maximum Allowable Concentration; Middle Aged; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Yttrium Radioisotopes | 2007 |
7 other study(ies) available for yttrium radioisotopes and Liver Diseases
| Article | Year |
|---|---|
A new animal model of atrophy-hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits.
Topics: Animals; Atrophy; Female; Hypertrophy; Liver; Liver Diseases; Rabbits; Yttrium Radioisotopes | 2022 |
Incidence of Radioembolization-Induced Liver Disease and Liver Toxicity Following Repeat 90Y-Radioembolization: Outcomes at a Large Tertiary Care Center.
Topics: Adult; Aged; Aged, 80 and over; Embolization, Therapeutic; Female; Humans; Incidence; Liver; Liver Diseases; Male; Microspheres; Middle Aged; Radiation Injuries; Retrospective Studies; Tertiary Care Centers; Yttrium Radioisotopes | 2020 |
Gastrohepatic Fistula After Y-90 Embolization of Hepatocellular Carcinoma.
Topics: Aged; Angiography; Carcinoma, Hepatocellular; Digestive System Fistula; Embolization, Therapeutic; Gastric Fistula; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Yttrium Radioisotopes | 2021 |
Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases.
Topics: Adult; Biopsy; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Microspheres; Middle Aged; Predictive Value of Tests; Radiation Injuries; Radiopharmaceuticals; Risk Factors; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Toxicities after radioembolization with yttrium-90 SIR-spheres: incidence and contributing risk factors at a single center.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Bilirubin; Biomarkers; Embolization, Therapeutic; Female; Humans; Incidence; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Philadelphia; Radiation Injuries; Radiopharmaceuticals; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult; Yttrium Radioisotopes | 2011 |
Safety of repeated yttrium-90 radioembolization.
Topics: Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Humans; Liver; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Microspheres; Middle Aged; Odds Ratio; Radiation Injuries; Retreatment; Retrospective Studies; Risk Factors; Yttrium Radioisotopes | 2013 |
Yttrium-90 microspheres (TheraSphere and SIR-Spheres) for the treatment of unresectable hepatocellular carcinoma.
Topics: Brachytherapy; Canada; Carcinoma, Hepatocellular; Device Approval; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Diseases; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Treatment Outcome; United States; Yttrium Radioisotopes | 2007 |